5-year survival and toxicity results of SIB radiotherapy in (very) high-risk prostate cancer

被引：0
|
作者：
Masson, I. [1 ]
Guerin-Charbonnel, C. [2 ]
Azria, D. [3 ]
Pommier, P. [4 ]
Mesgouez-Nebout, N. [5 ]
Giraud, P. [6 ]
Peiffert, D. [7 ]
Chauvet, B. [8 ]
Dudouet, P. [9 ]
Salem, N. [10 ]
Noel, G. [11 ]
Khalifa, J. [12 ]
Latorzeff, I. [13 ]
Mahe, M. A. [14 ]
Supiot, S. [15 ]
机构：
[1] Inst Cancerol Ouest Rene Gauducheau, Radiotherapy, Nantes, France
[2] Inst Cancerol Ouest Rene Gauducheau, Clin Trial Sponsor Unit Biometry, Nantes, France
[3] Inst Reg Canc Montpellier ICM, Federat Univ Oncol Radiotherapie FOROM, Montpellier, France
[4] Leon Berard Ctr, Radiotherapy, Lyon, France
[5] Inst Cancerol Ouest Paul Papin, Radiotherapy, Angers, France
[6] Georges Pompidou European Hosp, Radiotherapy, Paris, France
[7] Lorraine Canc Inst, Radiotherapy, Vandoeuvre Les Nancy, France
[8] Sainte Catherine Inst, Radiotherapy, Avignon, France
[9] Pont Chaume Clin, Radiotherapy, Montauban, Tarn & Garonne, France
[10] Paoli Calmettes Inst, Radiotherapy, Marseille, France
[11] Cancerol Inst Strasbourg Europe, Radiotherapy, Strasbourg, France
[12] Inst Univ Canc Toulouse Oncopole IUCT Oncopole, Radiotherapy, Toulouse, France
[13] Pasteur Clin, Radiotherapy, Toulouse, France
[14] Francois Baclesse Canc Ctr, Radiotherapy, Caen, France
[15] Inst Cancerol Ouest Rene Gauducheau, Radiotherapy, Nantes, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1465
引用
收藏
页码：S1186 / S1187
页数：2
相关论文
共 50 条
  • [31] Pelvic proton radiotherapy for high-risk prostate cancer
    Chera, B. S.
    Vargas, C.
    Flampouri, S.
    Morris, C. G.
    Yeung, D.
    Olivier, K.
    Duvvuri, S.
    Li, Z.
    Mendenhall, N. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S326 - S326
  • [32] Use and timing of radiotherapy in high-risk prostate cancer
    Ward, JF
    Blute, ML
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (23): : 2817 - 2817
  • [33] Radiotherapy after prostatectomy in high-risk prostate cancer
    Roviello, G.
    Villari, D.
    Nesi, G.
    Detti, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (11): : 2139 - 2140
  • [34] Is surgery superior to radiotherapy for high-risk prostate cancer?
    Eastham, James A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 438 - 438
  • [35] Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer
    Berkut, M., V
    Artemjeva, A. S.
    Reva, S. A.
    Tolmachev, S. S.
    Petrov, S. B.
    Nosov, A. K.
    ONKOUROLOGIYA, 2020, 16 (01): : 54 - 63
  • [36] Improving outcomes in high-risk prostate cancer with radiotherapy
    Polkinghorn, William R.
    Zelefsky, Michael J.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (06) : 333 - 337
  • [37] Very High-risk breast screening at King's College Hospital - A 5-year review
    Patil, Monica
    Peacock, Clare
    Wijesuriya, Shalini
    Michell, Michael
    Wasan, Rema
    Satchithananda, Keshtra
    Patel, Nikhil
    Batohi, Bhavna
    Rahim, Rumana
    Morel, Juliet
    BREAST CANCER RESEARCH, 2021, 23 (SUPPL 2)
  • [38] Results of surgery for high-risk prostate cancer
    Joniau, Steven
    Tosco, Lorenzo
    Briganti, Alberto
    Vanden Broeck, Thomas
    Gontero, Paolo
    Karnes, R. Jeffrey
    Spahn, Martin
    Van Poppel, Hein
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 342 - 348
  • [39] Survival after Radical Prostatectomy vs Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter
    Yu, Wenxiao
    Guo, Jun
    JOURNAL OF UROLOGY, 2022, 207 (02): : 478 - 479
  • [40] Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Reply
    Chierigo, Francesco
    Borghesi, Marco
    Mantica, Guglielmo
    Terrone, Carlo
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2022, 208 (01): : 224 - 224
12345